News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Daily News Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients Shelley Wood December 22, 2021
News Daily News Traditional Cath Lab Practices Scrutinized, Some Debunked, in AHA Statement Todd Neale July 05, 2021
News Daily News Fall in Hemoglobin Without Overt Bleeding May Be Prognostic in ACS Todd Neale January 26, 2021
News Daily News Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan Shelley Wood January 07, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Conference News EuroPCR 2020 Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients Michael O'Riordan June 30, 2020
News Conference News ESC 2018 MATRIX: 1-Year Results Confirm Superiority of Transradial PCI Michael O'Riordan August 25, 2018
News Daily News Radial Access Best for PCI Following Thrombolysis in STEMI Michael O'Riordan November 27, 2017
News Daily News Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI Todd Neale May 22, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab Yael L. Maxwell December 06, 2016
News Daily News Ensayo EUCLID: Ticagrelor No es Más Beneficioso que Clopidogrel en la Prevención de Episodios CV en Pacientes con EAP Sintomática Shelley Wood October 07, 2016
News Daily News No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX Shelley Wood October 03, 2016
News Daily News Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows Yael L. Maxwell September 15, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016